Recombinant Vaccines Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025 the global recombinant vaccines market is expanding at a CAGR of 6.4% from 2017 to 2025.
Browse Full Report here http://www.acutemarketreports.com/report/recombinant-vaccines-market
Recombinant vaccines are third generation vaccines, produced by using genetic engineering or recombinant DNA technology. It is expected that the global recombinant vaccines market will demonstrate lucrative market growth during the forecast period as these vaccines are more advanced as against the conventional alternatives. Expected launch of recombinant vaccines such as VPM1002 (BCG), EBOV-GP (ebola), Shingrix (herpes zoster), GSK-2189242A (pneumococcal infections), ID-93 (tuberculosis), PROSTVAC-VF etc. (prostate cancer) would further assist market growth during forecast period.
For the purpose of the study, the global human recombinant vaccines market is segmented on the basis of disease types such as infectious diseases and cancer. Infectious diseases are further categorized as hepatitis B infection, herpes zoster infection, influenza infection and other infectious diseases. At present, hepatitis B infection segment holds the largest market share because it is being recommended by different agencies such as the Centers for Disease Control and Prevention (CDC), the American Academy of Pediatrics (AAP) and other prominent bodies. Moreover, these vaccines are involved in the World Health Organization’s (WHO) list of essential medicines. North America is the current leader in recombinant vaccines market and the dominance is essentially due to early adoption of novel therapeutics, expected launch of new recombinant vaccines, greater cost of vaccines and recommended immunization program by the government agencies. Additionally, Asia Pacific is estimated to show the fastest market growth over the forecast period due to growing initiatives of government agencies in immunization programs, rising healthcare awareness and developing healthcare infrastructure.
Browse the complete report at http://www.acutemarketreports.com/report/recombinant-vaccines-market
Market Competition Assessment:
The recombinant vaccines market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Bharat Biotech, GlaxoSmithKline Plc., MedImmune, LLC, Merck & Co. Inc., Novartis AG, Pfizer Inc., Protein Science Corporation, Sanofi S A, Serum Institute of India, and others.
Key Market Movements:
• Rising incidence of various infectious diseases, growing investment in R&D for development of recombinant vaccines, advancement in recombinant vaccines technology, promising pipeline vaccines such as VPM1002, EBOV-GP, Shingrix, GSK-2189242A, ID-93, PROSTVAC-VF etc. would assist recombinant vaccines market growth during forecast period
• Recombinant vaccines offer some advantages over conventional vaccines such as greater simplicity, reliability and faster production, which are consequently driving the growth of recombinant vaccines market globally
Download Free Request Sample: http://www.acutemarketreports.com/request-free-sample/110946
Table of Content:
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
Chapter 2 Executive Summary
2.1 Global Recombinant Vaccines Market Snapshot
2.2 Global Recombinant Vaccines Market, by Disease (US$ Bn)
2.3 Global Recombinant Vaccines Market Share, by Geography, 2016 (Value %)
Chapter 3 Recombinant Vaccines Market Analysis
3.1 Global Recombinant Vaccines Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.3 Attractive Investment Proposition, 2016
3.4 Competitive Landscape of Key Players in Recombinant Vaccines Market
3.5 Top 3 Countries
Chapter 7 Company Profiles
7.1 Bharat Biotech
7.2 GlaxoSmithKline Plc.
7.3 MedImmune, LLC
7.4 Merck & Co. Inc.
7.5 Novartis AG
7.6 Pfizer Inc.
7.7 Protein Science Corporation
7.8 Sanofi Aventis
7.9 Serum Institute of India
About – Acute Market Reports:
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Name: Chris Paul
ACUTE MARKET REPORTS
Designation: Global Sales Manager
Toll Free (US/CANADA): +1-855-455-8662